Search Results

Displaying: 25 / 100 / 200 results

Ordered by: Date (newest first) / Date (oldest first)

Daiichi Sankyo steps out after Sun-Ranbaxy merger

22 April 2015 Business

Ranbaxy’s Japanese owner has sold off its stake in the merged company, but will retain its business partnership

Environmental research goes private

1 April 2015 Business

Exclusive interview with Fera chief Hilary Aldridge as the UK's Food and Environment Research Agency becomes majority-owned by Capita

Valeant heads off Endo bid for Salix

25 March 2015 Business

Bid raised to $15.8 billion in cash after rival offer from Irish firm

Measuring up

24 March 2015 Editorial

Business leader: How should we assess companies’ performance?

BASF introduces bio-based polyTHF

13 March 2015 Business

Process uses 1,4-butanediol from microbial digestion of sugar feedstocks to make component of polyester and polyurethane materials

Mallinckrodt to buy Ikaria to expand in US hospitals

9 March 2015 Business

$2.3bn deal brings nitric oxide ventilator system for newborns with respiratory failure

J&J to sell cardiac devices to wholesaler Cardinal

3 March 2015 Business

Commodity technology no longer fits with company’s focus on growth and innovation

AstraZeneca to spin off anti-infectives research

2 March 2015 Business

Early-stage research will transfer to a new company, while AZ and MedImmune retain late-stage programmes

Asahi Kasei to buy Polypore for battery materials

26 February 2015 Business

$2.2bn deal adds to Japanese consolidation in energy storage

B-MS bolsters immuno-oncology with pair of deals

24 February 2015 Business

Firm will acquire Flexus Biosciences and collaborate with Rigel

Catalytic carbon dioxide convertors

24 February 2015 Business

Company profile: Econic Technologies makes catalysts that build carbon dioxide into performance polymers

Valeant to buy Salix for $14.5bn

23 February 2015 Business

Companies expect $500m in savings through ‘R&D rationalisation’

Europe approves stem cell therapy

23 February 2015 Business

Treatment for burn-damaged eyes uses patient’s own scaffold-grown cells

Generic: the unbranding of modern medicine

19 February 2015 Review

The same but not the same

Teva wins generic esomeprazole race

16 February 2015 Business

US approval of heartburn drug after Ranbaxy version was withdrawn by regulators

US approves internal tissue glue

16 February 2015 Business

Urethane-based TissuGlu aids healing after abdominal surgery

Fatal blast at Indian chemical plant

3 February 2015 Business

One worker killed and four injured at Survival Technologies plant in Ankleshwar

Shire deepens rare disease focus with NPS buyout

26 January 2015 Business

Approval of parathyroid hormone drug further validates acquisition decision

UK calls for fracking restrictions

26 January 2015 Business

Environment committee wants to protect national parks and tighten regulation

Biogen Idec to buy Convergence for pain pipeline

12 January 2015 Business

UK firm will remain intact as a ‘centre of excellence’ in pain R&D for Biogen

EU recommends Parkinson’s drug for approval

24 December 2014 Business

First new molecule for a decade, but Alzheimer’s still posing challenges as antibody treatment withdrawn from trials

EU chemicals regulator scolded over animal testing

24 December 2014 Business

Ombudsman says ECHA isn’t doing enough to require alternative, non-animal methods

Consumer products firms fined for French price fixing

23 December 2014 Business

€950m fines for ‘friends clubs’ that pushed up prices for home and personal care products

Solving iron’s solubility problem

10 December 2014 Business

Technology profile: MRC Human Nutrition Research - anaemia supplements with fewer side effects

Otsuka to buy neurology specialist Avanir

4 December 2014 Business

$3.5bn deal adds to Otsuka’s mental health portfolio and strengthens its US presence